Global Microneedle Flu Vaccine Market Growth 2024-2031

Report ID: 1402830 | Published Date: Jan 2025 | No. of Page: 95 | Base Year: 2024 | Rating: 4.3 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Microneedle Flu Vaccine Annual Sales 2017-2028
        2.1.2 World Current & Future Analysis for Microneedle Flu Vaccine by Geographic Region, 2017, 2022 & 2028
        2.1.3 World Current & Future Analysis for Microneedle Flu Vaccine by Country/Region, 2017, 2022 & 2028
    2.2 Microneedle Flu Vaccine Segment by Type
        2.2.1 Solid Microneedle
        2.2.2 Hollow Microneedle
        2.2.3 Coated Microneedle
        2.2.4 Dissolving Microneedle
    2.3 Microneedle Flu Vaccine Sales by Type
        2.3.1 Global Microneedle Flu Vaccine Sales Market Share by Type (2017-2022)
        2.3.2 Global Microneedle Flu Vaccine Revenue and Market Share by Type (2017-2022)
        2.3.3 Global Microneedle Flu Vaccine Sale Price by Type (2017-2022)
    2.4 Microneedle Flu Vaccine Segment by Application
        2.4.1 Influenza A
        2.4.2 Influenza B
    2.5 Microneedle Flu Vaccine Sales by Application
        2.5.1 Global Microneedle Flu Vaccine Sale Market Share by Application (2017-2022)
        2.5.2 Global Microneedle Flu Vaccine Revenue and Market Share by Application (2017-2022)
        2.5.3 Global Microneedle Flu Vaccine Sale Price by Application (2017-2022)
3 Global Microneedle Flu Vaccine by Company
    3.1 Global Microneedle Flu Vaccine Breakdown Data by Company
        3.1.1 Global Microneedle Flu Vaccine Annual Sales by Company (2020-2022)
        3.1.2 Global Microneedle Flu Vaccine Sales Market Share by Company (2020-2022)
    3.2 Global Microneedle Flu Vaccine Annual Revenue by Company (2020-2022)
        3.2.1 Global Microneedle Flu Vaccine Revenue by Company (2020-2022)
        3.2.2 Global Microneedle Flu Vaccine Revenue Market Share by Company (2020-2022)
    3.3 Global Microneedle Flu Vaccine Sale Price by Company
    3.4 Key Manufacturers Microneedle Flu Vaccine Producing Area Distribution, Sales Area, Product Type
        3.4.1 Key Manufacturers Microneedle Flu Vaccine Product Location Distribution
        3.4.2 Players Microneedle Flu Vaccine Products Offered
    3.5 Market Concentration Rate Analysis
        3.5.1 Competition Landscape Analysis
        3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    3.6 New Products and Potential Entrants
    3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Microneedle Flu Vaccine by Geographic Region
    4.1 World Historic Microneedle Flu Vaccine Market Size by Geographic Region (2017-2022)
        4.1.1 Global Microneedle Flu Vaccine Annual Sales by Geographic Region (2017-2022)
        4.1.2 Global Microneedle Flu Vaccine Annual Revenue by Geographic Region
    4.2 World Historic Microneedle Flu Vaccine Market Size by Country/Region (2017-2022)
        4.2.1 Global Microneedle Flu Vaccine Annual Sales by Country/Region (2017-2022)
        4.2.2 Global Microneedle Flu Vaccine Annual Revenue by Country/Region
    4.3 Americas Microneedle Flu Vaccine Sales Growth
    4.4 APAC Microneedle Flu Vaccine Sales Growth
    4.5 Europe Microneedle Flu Vaccine Sales Growth
    4.6 Middle East & Africa Microneedle Flu Vaccine Sales Growth
5 Americas
    5.1 Americas Microneedle Flu Vaccine Sales by Country
        5.1.1 Americas Microneedle Flu Vaccine Sales by Country (2017-2022)
        5.1.2 Americas Microneedle Flu Vaccine Revenue by Country (2017-2022)
    5.2 Americas Microneedle Flu Vaccine Sales by Type
    5.3 Americas Microneedle Flu Vaccine Sales by Application
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil
6 APAC
    6.1 APAC Microneedle Flu Vaccine Sales by Region
        6.1.1 APAC Microneedle Flu Vaccine Sales by Region (2017-2022)
        6.1.2 APAC Microneedle Flu Vaccine Revenue by Region (2017-2022)
    6.2 APAC Microneedle Flu Vaccine Sales by Type
    6.3 APAC Microneedle Flu Vaccine Sales by Application
    6.4 China
    6.5 Japan
    6.6 South Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
    6.10 China Taiwan
7 Europe
    7.1 Europe Microneedle Flu Vaccine by Country
        7.1.1 Europe Microneedle Flu Vaccine Sales by Country (2017-2022)
        7.1.2 Europe Microneedle Flu Vaccine Revenue by Country (2017-2022)
    7.2 Europe Microneedle Flu Vaccine Sales by Type
    7.3 Europe Microneedle Flu Vaccine Sales by Application
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia
8 Middle East & Africa
    8.1 Middle East & Africa Microneedle Flu Vaccine by Country
        8.1.1 Middle East & Africa Microneedle Flu Vaccine Sales by Country (2017-2022)
        8.1.2 Middle East & Africa Microneedle Flu Vaccine Revenue by Country (2017-2022)
    8.2 Middle East & Africa Microneedle Flu Vaccine Sales by Type
    8.3 Middle East & Africa Microneedle Flu Vaccine Sales by Application
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries
9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
    10.1 Raw Material and Suppliers
    10.2 Manufacturing Cost Structure Analysis of Microneedle Flu Vaccine
    10.3 Manufacturing Process Analysis of Microneedle Flu Vaccine
    10.4 Industry Chain Structure of Microneedle Flu Vaccine
11 Marketing, Distributors and Customer
    11.1 Sales Channel
        11.1.1 Direct Channels
        11.1.2 Indirect Channels
    11.2 Microneedle Flu Vaccine Distributors
    11.3 Microneedle Flu Vaccine Customer
12 World Forecast Review for Microneedle Flu Vaccine by Geographic Region
    12.1 Global Microneedle Flu Vaccine Market Size Forecast by Region
        12.1.1 Global Microneedle Flu Vaccine Forecast by Region (2023-2028)
        12.1.2 Global Microneedle Flu Vaccine Annual Revenue Forecast by Region (2023-2028)
    12.2 Americas Forecast by Country
    12.3 APAC Forecast by Region
    12.4 Europe Forecast by Country
    12.5 Middle East & Africa Forecast by Country
    12.6 Global Microneedle Flu Vaccine Forecast by Type
    12.7 Global Microneedle Flu Vaccine Forecast by Application
13 Key Players Analysis
    13.1 Sanofi
        13.1.1 Sanofi Company Information
        13.1.2 Sanofi Microneedle Flu Vaccine Product Offered
        13.1.3 Sanofi Microneedle Flu Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.1.4 Sanofi Main Business Overview
        13.1.5 Sanofi Latest Developments
    13.2 GC Pharma
        13.2.1 GC Pharma Company Information
        13.2.2 GC Pharma Microneedle Flu Vaccine Product Offered
        13.2.3 GC Pharma Microneedle Flu Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.2.4 GC Pharma Main Business Overview
        13.2.5 GC Pharma Latest Developments
    13.3 Debiotech
        13.3.1 Debiotech Company Information
        13.3.2 Debiotech Microneedle Flu Vaccine Product Offered
        13.3.3 Debiotech Microneedle Flu Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.3.4 Debiotech Main Business Overview
        13.3.5 Debiotech Latest Developments
    13.4 NanoPass Technologies
        13.4.1 NanoPass Technologies Company Information
        13.4.2 NanoPass Technologies Microneedle Flu Vaccine Product Offered
        13.4.3 NanoPass Technologies Microneedle Flu Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.4.4 NanoPass Technologies Main Business Overview
        13.4.5 NanoPass Technologies Latest Developments
    13.5 Corium International
        13.5.1 Corium International Company Information
        13.5.2 Corium International Microneedle Flu Vaccine Product Offered
        13.5.3 Corium International Microneedle Flu Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.5.4 Corium International Main Business Overview
        13.5.5 Corium International Latest Developments
    13.6 Becton Dickinson and Company
        13.6.1 Becton Dickinson and Company Company Information
        13.6.2 Becton Dickinson and Company Microneedle Flu Vaccine Product Offered
        13.6.3 Becton Dickinson and Company Microneedle Flu Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.6.4 Becton Dickinson and Company Main Business Overview
        13.6.5 Becton Dickinson and Company Latest Developments
    13.7 FluGen
        13.7.1 FluGen Company Information
        13.7.2 FluGen Microneedle Flu Vaccine Product Offered
        13.7.3 FluGen Microneedle Flu Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.7.4 FluGen Main Business Overview
        13.7.5 FluGen Latest Developments
    13.8 CosMED Pharmaceuticals
        13.8.1 CosMED Pharmaceuticals Company Information
        13.8.2 CosMED Pharmaceuticals Microneedle Flu Vaccine Product Offered
        13.8.3 CosMED Pharmaceuticals Microneedle Flu Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.8.4 CosMED Pharmaceuticals Main Business Overview
        13.8.5 CosMED Pharmaceuticals Latest Developments
    13.9 Microdermics and OraSure Technologies
        13.9.1 Microdermics and OraSure Technologies Company Information
        13.9.2 Microdermics and OraSure Technologies Microneedle Flu Vaccine Product Offered
        13.9.3 Microdermics and OraSure Technologies Microneedle Flu Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.9.4 Microdermics and OraSure Technologies Main Business Overview
        13.9.5 Microdermics and OraSure Technologies Latest Developments
14 Research Findings and Conclusion

List of Tables
    Table 1. Microneedle Flu Vaccine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
    Table 2. Microneedle Flu Vaccine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
    Table 3. Major Players of Solid Microneedle
    Table 4. Major Players of Hollow Microneedle
    Table 5. Major Players of Coated Microneedle
    Table 6. Major Players of Dissolving Microneedle
    Table 7. Global Microneedle Flu Vaccine Sales by Type (2017-2022) & (K Units)
    Table 8. Global Microneedle Flu Vaccine Sales Market Share by Type (2017-2022)
    Table 9. Global Microneedle Flu Vaccine Revenue by Type (2017-2022) & ($ million)
    Table 10. Global Microneedle Flu Vaccine Revenue Market Share by Type (2017-2022)
    Table 11. Global Microneedle Flu Vaccine Sale Price by Type (2017-2022) & (US$/Unit)
    Table 12. Global Microneedle Flu Vaccine Sales by Application (2017-2022) & (K Units)
    Table 13. Global Microneedle Flu Vaccine Sales Market Share by Application (2017-2022)
    Table 14. Global Microneedle Flu Vaccine Revenue by Application (2017-2022)
    Table 15. Global Microneedle Flu Vaccine Revenue Market Share by Application (2017-2022)
    Table 16. Global Microneedle Flu Vaccine Sale Price by Application (2017-2022) & (US$/Unit)
    Table 17. Global Microneedle Flu Vaccine Sales by Company (2020-2022) & (K Units)
    Table 18. Global Microneedle Flu Vaccine Sales Market Share by Company (2020-2022)
    Table 19. Global Microneedle Flu Vaccine Revenue by Company (2020-2022) ($ Millions)
    Table 20. Global Microneedle Flu Vaccine Revenue Market Share by Company (2020-2022)
    Table 21. Global Microneedle Flu Vaccine Sale Price by Company (2020-2022) & (US$/Unit)
    Table 22. Key Manufacturers Microneedle Flu Vaccine Producing Area Distribution and Sales Area
    Table 23. Players Microneedle Flu Vaccine Products Offered
    Table 24. Microneedle Flu Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    Table 25. New Products and Potential Entrants
    Table 26. Mergers & Acquisitions, Expansion
    Table 27. Global Microneedle Flu Vaccine Sales by Geographic Region (2017-2022) & (K Units)
    Table 28. Global Microneedle Flu Vaccine Sales Market Share Geographic Region (2017-2022)
    Table 29. Global Microneedle Flu Vaccine Revenue by Geographic Region (2017-2022) & ($ millions)
    Table 30. Global Microneedle Flu Vaccine Revenue Market Share by Geographic Region (2017-2022)
    Table 31. Global Microneedle Flu Vaccine Sales by Country/Region (2017-2022) & (K Units)
    Table 32. Global Microneedle Flu Vaccine Sales Market Share by Country/Region (2017-2022)
    Table 33. Global Microneedle Flu Vaccine Revenue by Country/Region (2017-2022) & ($ millions)
    Table 34. Global Microneedle Flu Vaccine Revenue Market Share by Country/Region (2017-2022)
    Table 35. Americas Microneedle Flu Vaccine Sales by Country (2017-2022) & (K Units)
    Table 36. Americas Microneedle Flu Vaccine Sales Market Share by Country (2017-2022)
    Table 37. Americas Microneedle Flu Vaccine Revenue by Country (2017-2022) & ($ Millions)
    Table 38. Americas Microneedle Flu Vaccine Revenue Market Share by Country (2017-2022)
    Table 39. Americas Microneedle Flu Vaccine Sales by Type (2017-2022) & (K Units)
    Table 40. Americas Microneedle Flu Vaccine Sales Market Share by Type (2017-2022)
    Table 41. Americas Microneedle Flu Vaccine Sales by Application (2017-2022) & (K Units)
    Table 42. Americas Microneedle Flu Vaccine Sales Market Share by Application (2017-2022)
    Table 43. APAC Microneedle Flu Vaccine Sales by Region (2017-2022) & (K Units)
    Table 44. APAC Microneedle Flu Vaccine Sales Market Share by Region (2017-2022)
    Table 45. APAC Microneedle Flu Vaccine Revenue by Region (2017-2022) & ($ Millions)
    Table 46. APAC Microneedle Flu Vaccine Revenue Market Share by Region (2017-2022)
    Table 47. APAC Microneedle Flu Vaccine Sales by Type (2017-2022) & (K Units)
    Table 48. APAC Microneedle Flu Vaccine Sales Market Share by Type (2017-2022)
    Table 49. APAC Microneedle Flu Vaccine Sales by Application (2017-2022) & (K Units)
    Table 50. APAC Microneedle Flu Vaccine Sales Market Share by Application (2017-2022)
    Table 51. Europe Microneedle Flu Vaccine Sales by Country (2017-2022) & (K Units)
    Table 52. Europe Microneedle Flu Vaccine Sales Market Share by Country (2017-2022)
    Table 53. Europe Microneedle Flu Vaccine Revenue by Country (2017-2022) & ($ Millions)
    Table 54. Europe Microneedle Flu Vaccine Revenue Market Share by Country (2017-2022)
    Table 55. Europe Microneedle Flu Vaccine Sales by Type (2017-2022) & (K Units)
    Table 56. Europe Microneedle Flu Vaccine Sales Market Share by Type (2017-2022)
    Table 57. Europe Microneedle Flu Vaccine Sales by Application (2017-2022) & (K Units)
    Table 58. Europe Microneedle Flu Vaccine Sales Market Share by Application (2017-2022)
    Table 59. Middle East & Africa Microneedle Flu Vaccine Sales by Country (2017-2022) & (K Units)
    Table 60. Middle East & Africa Microneedle Flu Vaccine Sales Market Share by Country (2017-2022)
    Table 61. Middle East & Africa Microneedle Flu Vaccine Revenue by Country (2017-2022) & ($ Millions)
    Table 62. Middle East & Africa Microneedle Flu Vaccine Revenue Market Share by Country (2017-2022)
    Table 63. Middle East & Africa Microneedle Flu Vaccine Sales by Type (2017-2022) & (K Units)
    Table 64. Middle East & Africa Microneedle Flu Vaccine Sales Market Share by Type (2017-2022)
    Table 65. Middle East & Africa Microneedle Flu Vaccine Sales by Application (2017-2022) & (K Units)
    Table 66. Middle East & Africa Microneedle Flu Vaccine Sales Market Share by Application (2017-2022)
    Table 67. Key Market Drivers & Growth Opportunities of Microneedle Flu Vaccine
    Table 68. Key Market Challenges & Risks of Microneedle Flu Vaccine
    Table 69. Key Industry Trends of Microneedle Flu Vaccine
    Table 70. Microneedle Flu Vaccine Raw Material
    Table 71. Key Suppliers of Raw Materials
    Table 72. Microneedle Flu Vaccine Distributors List
    Table 73. Microneedle Flu Vaccine Customer List
    Table 74. Global Microneedle Flu Vaccine Sales Forecast by Region (2023-2028) & (K Units)
    Table 75. Global Microneedle Flu Vaccine Sales Market Forecast by Region
    Table 76. Global Microneedle Flu Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 77. Global Microneedle Flu Vaccine Revenue Market Share Forecast by Region (2023-2028)
    Table 78. Americas Microneedle Flu Vaccine Sales Forecast by Country (2023-2028) & (K Units)
    Table 79. Americas Microneedle Flu Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 80. APAC Microneedle Flu Vaccine Sales Forecast by Region (2023-2028) & (K Units)
    Table 81. APAC Microneedle Flu Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 82. Europe Microneedle Flu Vaccine Sales Forecast by Country (2023-2028) & (K Units)
    Table 83. Europe Microneedle Flu Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 84. Middle East & Africa Microneedle Flu Vaccine Sales Forecast by Country (2023-2028) & (K Units)
    Table 85. Middle East & Africa Microneedle Flu Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 86. Global Microneedle Flu Vaccine Sales Forecast by Type (2023-2028) & (K Units)
    Table 87. Global Microneedle Flu Vaccine Sales Market Share Forecast by Type (2023-2028)
    Table 88. Global Microneedle Flu Vaccine Revenue Forecast by Type (2023-2028) & ($ Millions)
    Table 89. Global Microneedle Flu Vaccine Revenue Market Share Forecast by Type (2023-2028)
    Table 90. Global Microneedle Flu Vaccine Sales Forecast by Application (2023-2028) & (K Units)
    Table 91. Global Microneedle Flu Vaccine Sales Market Share Forecast by Application (2023-2028)
    Table 92. Global Microneedle Flu Vaccine Revenue Forecast by Application (2023-2028) & ($ Millions)
    Table 93. Global Microneedle Flu Vaccine Revenue Market Share Forecast by Application (2023-2028)
    Table 94. Sanofi Basic Information, Microneedle Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
    Table 95. Sanofi Microneedle Flu Vaccine Product Offered
    Table 96. Sanofi Microneedle Flu Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 97. Sanofi Main Business
    Table 98. Sanofi Latest Developments
    Table 99. GC Pharma Basic Information, Microneedle Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
    Table 100. GC Pharma Microneedle Flu Vaccine Product Offered
    Table 101. GC Pharma Microneedle Flu Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 102. GC Pharma Main Business
    Table 103. GC Pharma Latest Developments
    Table 104. Debiotech Basic Information, Microneedle Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
    Table 105. Debiotech Microneedle Flu Vaccine Product Offered
    Table 106. Debiotech Microneedle Flu Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 107. Debiotech Main Business
    Table 108. Debiotech Latest Developments
    Table 109. NanoPass Technologies Basic Information, Microneedle Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
    Table 110. NanoPass Technologies Microneedle Flu Vaccine Product Offered
    Table 111. NanoPass Technologies Microneedle Flu Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 112. NanoPass Technologies Main Business
    Table 113. NanoPass Technologies Latest Developments
    Table 114. Corium International Basic Information, Microneedle Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
    Table 115. Corium International Microneedle Flu Vaccine Product Offered
    Table 116. Corium International Microneedle Flu Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 117. Corium International Main Business
    Table 118. Corium International Latest Developments
    Table 119. Becton Dickinson and Company Basic Information, Microneedle Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
    Table 120. Becton Dickinson and Company Microneedle Flu Vaccine Product Offered
    Table 121. Becton Dickinson and Company Microneedle Flu Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 122. Becton Dickinson and Company Main Business
    Table 123. Becton Dickinson and Company Latest Developments
    Table 124. FluGen Basic Information, Microneedle Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
    Table 125. FluGen Microneedle Flu Vaccine Product Offered
    Table 126. FluGen Microneedle Flu Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 127. FluGen Main Business
    Table 128. FluGen Latest Developments
    Table 129. CosMED Pharmaceuticals Basic Information, Microneedle Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
    Table 130. CosMED Pharmaceuticals Microneedle Flu Vaccine Product Offered
    Table 131. CosMED Pharmaceuticals Microneedle Flu Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 132. CosMED Pharmaceuticals Main Business
    Table 133. CosMED Pharmaceuticals Latest Developments
    Table 134. Microdermics and OraSure Technologies Basic Information, Microneedle Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
    Table 135. Microdermics and OraSure Technologies Microneedle Flu Vaccine Product Offered
    Table 136. Microdermics and OraSure Technologies Microneedle Flu Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 137. Microdermics and OraSure Technologies Main Business
    Table 138. Microdermics and OraSure Technologies Latest Developments
List of Figures
    Figure 1. Picture of Microneedle Flu Vaccine
    Figure 2. Microneedle Flu Vaccine Report Years Considered
    Figure 3. Research Objectives
    Figure 4. Research Methodology
    Figure 5. Research Process and Data Source
    Figure 6. Global Microneedle Flu Vaccine Sales Growth Rate 2017-2028 (K Units)
    Figure 7. Global Microneedle Flu Vaccine Revenue Growth Rate 2017-2028 ($ Millions)
    Figure 8. Microneedle Flu Vaccine Sales by Region (2021 & 2028) & ($ millions)
    Figure 9. Product Picture of Solid Microneedle
    Figure 10. Product Picture of Hollow Microneedle
    Figure 11. Product Picture of Coated Microneedle
    Figure 12. Product Picture of Dissolving Microneedle
    Figure 13. Global Microneedle Flu Vaccine Sales Market Share by Type in 2021
    Figure 14. Global Microneedle Flu Vaccine Revenue Market Share by Type (2017-2022)
    Figure 15. Microneedle Flu Vaccine Consumed in Influenza A
    Figure 16. Global Microneedle Flu Vaccine Market: Influenza A (2017-2022) & (K Units)
    Figure 17. Microneedle Flu Vaccine Consumed in Influenza B
    Figure 18. Global Microneedle Flu Vaccine Market: Influenza B (2017-2022) & (K Units)
    Figure 19. Global Microneedle Flu Vaccine Sales Market Share by Application (2017-2022)
    Figure 20. Global Microneedle Flu Vaccine Revenue Market Share by Application in 2021
    Figure 21. Microneedle Flu Vaccine Revenue Market by Company in 2021 ($ Million)
    Figure 22. Global Microneedle Flu Vaccine Revenue Market Share by Company in 2021
    Figure 23. Global Microneedle Flu Vaccine Sales Market Share by Geographic Region (2017-2022)
    Figure 24. Global Microneedle Flu Vaccine Revenue Market Share by Geographic Region in 2021
    Figure 25. Global Microneedle Flu Vaccine Sales Market Share by Region (2017-2022)
    Figure 26. Global Microneedle Flu Vaccine Revenue Market Share by Country/Region in 2021
    Figure 27. Americas Microneedle Flu Vaccine Sales 2017-2022 (K Units)
    Figure 28. Americas Microneedle Flu Vaccine Revenue 2017-2022 ($ Millions)
    Figure 29. APAC Microneedle Flu Vaccine Sales 2017-2022 (K Units)
    Figure 30. APAC Microneedle Flu Vaccine Revenue 2017-2022 ($ Millions)
    Figure 31. Europe Microneedle Flu Vaccine Sales 2017-2022 (K Units)
    Figure 32. Europe Microneedle Flu Vaccine Revenue 2017-2022 ($ Millions)
    Figure 33. Middle East & Africa Microneedle Flu Vaccine Sales 2017-2022 (K Units)
    Figure 34. Middle East & Africa Microneedle Flu Vaccine Revenue 2017-2022 ($ Millions)
    Figure 35. Americas Microneedle Flu Vaccine Sales Market Share by Country in 2021
    Figure 36. Americas Microneedle Flu Vaccine Revenue Market Share by Country in 2021
    Figure 37. United States Microneedle Flu Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 38. Canada Microneedle Flu Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 39. Mexico Microneedle Flu Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 40. Brazil Microneedle Flu Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 41. APAC Microneedle Flu Vaccine Sales Market Share by Region in 2021
    Figure 42. APAC Microneedle Flu Vaccine Revenue Market Share by Regions in 2021
    Figure 43. China Microneedle Flu Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 44. Japan Microneedle Flu Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 45. South Korea Microneedle Flu Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 46. Southeast Asia Microneedle Flu Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 47. India Microneedle Flu Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 48. Australia Microneedle Flu Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 49. Europe Microneedle Flu Vaccine Sales Market Share by Country in 2021
    Figure 50. Europe Microneedle Flu Vaccine Revenue Market Share by Country in 2021
    Figure 51. Germany Microneedle Flu Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 52. France Microneedle Flu Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 53. UK Microneedle Flu Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 54. Italy Microneedle Flu Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 55. Russia Microneedle Flu Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 56. Middle East & Africa Microneedle Flu Vaccine Sales Market Share by Country in 2021
    Figure 57. Middle East & Africa Microneedle Flu Vaccine Revenue Market Share by Country in 2021
    Figure 58. Egypt Microneedle Flu Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 59. South Africa Microneedle Flu Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 60. Israel Microneedle Flu Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 61. Turkey Microneedle Flu Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 62. GCC Country Microneedle Flu Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 63. Manufacturing Cost Structure Analysis of Microneedle Flu Vaccine in 2021
    Figure 64. Manufacturing Process Analysis of Microneedle Flu Vaccine
    Figure 65. Industry Chain Structure of Microneedle Flu Vaccine
    Figure 66. Channels of Distribution
    Figure 67. Distributors Profiles
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Global Microneedle Flu Vaccine Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Global Microneedle Flu Vaccine Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Global Microneedle Flu Vaccine Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports